Safety and Efficacy of Two Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density

Written by ClinicalTrials.gov

Category: Bone diseases

Published: 11 July 2011

Conditions: Osteopenia; Osteoporosis
Interventions: Drug: BPS804; Drug: placebo; Drug: BPS804; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - verified July 2011

Details: Last Updated: 11 July 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies